PL375032A1 - Kompozycja farmacetyczna zawierająca krystalicznyhemihydrat metanosulfonianu sibutraminy - Google Patents
Kompozycja farmacetyczna zawierająca krystalicznyhemihydrat metanosulfonianu sibutraminyInfo
- Publication number
- PL375032A1 PL375032A1 PL03375032A PL37503203A PL375032A1 PL 375032 A1 PL375032 A1 PL 375032A1 PL 03375032 A PL03375032 A PL 03375032A PL 37503203 A PL37503203 A PL 37503203A PL 375032 A1 PL375032 A1 PL 375032A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- sibutramine methanesulfonate
- crystalline sibutramine
- methanesulfonate hemihydrate
- hemihydrate
- Prior art date
Links
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 title 1
- 229960004425 sibutramine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20020060798 | 2002-10-05 | ||
| KR10-2003-0053752A KR100536750B1 (ko) | 2002-10-05 | 2003-08-04 | 시부트라민 메탄술폰산염의 결정성 반수화물을 포함하는약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375032A1 true PL375032A1 (pl) | 2005-11-14 |
Family
ID=36147018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375032A PL375032A1 (pl) | 2002-10-05 | 2003-09-25 | Kompozycja farmacetyczna zawierająca krystalicznyhemihydrat metanosulfonianu sibutraminy |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6900245B2 (pl) |
| EP (1) | EP1545484A4 (pl) |
| JP (1) | JP4278652B2 (pl) |
| AU (1) | AU2003264968B2 (pl) |
| BR (1) | BR0315084A (pl) |
| CA (1) | CA2501321C (pl) |
| HR (1) | HRP20050307A2 (pl) |
| MX (1) | MXPA05003355A (pl) |
| NO (1) | NO20052222L (pl) |
| NZ (1) | NZ538966A (pl) |
| PL (1) | PL375032A1 (pl) |
| RU (1) | RU2290924C2 (pl) |
| WO (1) | WO2004030663A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060084637A1 (en) * | 2004-10-18 | 2006-04-20 | Maria Alemany | Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
| US20060084636A1 (en) * | 2004-10-18 | 2006-04-20 | Maria Alemany | Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same |
| WO2006073292A1 (en) * | 2005-01-06 | 2006-07-13 | Cj Corporation | Inorganic acid salts of sibutramine |
| KR20060080817A (ko) * | 2005-01-06 | 2006-07-11 | 씨제이 주식회사 | 시부트라민의 디카복실산염 |
| KR20060080818A (ko) * | 2005-01-06 | 2006-07-11 | 씨제이 주식회사 | 시부트라민의 술폰산염 |
| KR100627687B1 (ko) * | 2005-04-20 | 2006-09-25 | 주식회사 씨티씨바이오 | 시부트라민 유리염기 함유 조성물 및 이의 제조방법 |
| JP4934293B2 (ja) * | 2005-07-05 | 2012-05-16 | コスモ石油株式会社 | 植物活力剤組成物 |
| KR100781882B1 (ko) * | 2005-07-12 | 2007-12-05 | 주식회사유한양행 | 시부트라민을 함유하는 약제학적 조성물 |
| KR100806673B1 (ko) | 2006-06-23 | 2008-03-03 | 주식회사 대희화학 | 결정상 시부트라민 프리베이스의 제조방법 |
| KR20100088992A (ko) * | 2009-02-02 | 2010-08-11 | 주식회사 대희화학 | (r)-시부트라민 염 및 그의 제조방법 |
| JP2013510097A (ja) * | 2009-11-03 | 2013-03-21 | リウ、リー | タンシノンiiaスルホン酸ナトリウム水和物、並びにその調製方法及び使用 |
| CN102786444A (zh) * | 2012-07-24 | 2012-11-21 | 上海瑞博化学有限公司 | 一种西布曲明类似物的磺酸盐的制备方法 |
| JP6910946B2 (ja) * | 2014-08-25 | 2021-07-28 | アイミューン セラピューティクス,インコーポレイテッド | タマゴのタンパク質製剤およびその製造方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA821577B (en) * | 1981-04-06 | 1983-03-30 | Boots Co Plc | Therapeutic agents |
| GB2098302B (en) * | 1981-05-13 | 1985-02-06 | Fort Vale Eng Ltd | Improvements in lids for pressure vessels |
| GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
| GB2184122B (en) * | 1985-12-17 | 1989-10-18 | Boots Co Plc | N,n-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methyl butylamine hydrochloride monohydrate |
| US20020006963A1 (en) * | 1992-06-23 | 2002-01-17 | Young James W. | Method of using and compositions comprising (-) sibutramine optionally in combination with other pharmacologically active compounds |
| US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
| GB9619757D0 (en) * | 1996-09-21 | 1996-11-06 | Knoll Ag | Chemical process |
| GB9619962D0 (en) * | 1996-09-25 | 1996-11-13 | Knoll Ag | Medical treatment |
| GB9619961D0 (en) * | 1996-09-25 | 1996-11-13 | Knoll Ag | Medical treatment |
| US6376554B1 (en) * | 1999-03-19 | 2002-04-23 | Knoll Pharmaceutical Company | Method of treating sexual dysfunction |
| AU3895300A (en) * | 1999-03-19 | 2000-10-09 | Knoll Pharmaceutical Company | Treatment of chronic fatigue syndrome |
| HUP0200501A3 (en) * | 1999-03-19 | 2004-03-29 | Abbott Gmbh & Co Kg | Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for treating sleep apnoea |
| TR200102695T2 (tr) * | 1999-03-19 | 2002-01-21 | Knoll Gmbh | Tedavi edici ilaçlarla ilişkili olarak kilo alımının kontrol edilmesi |
| AU3757300A (en) * | 1999-03-19 | 2000-10-09 | Knoll Pharmaceutical Company | Method of treating anxiety disorders |
| US6399826B1 (en) * | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| US6232347B1 (en) * | 2000-03-17 | 2001-05-15 | Knoll Pharmaceutical Company | Treatment of osteoarthritis |
| WO2002036540A2 (en) * | 2000-11-02 | 2002-05-10 | Torrent Pharmaceuticals Ltd | PROCESS FOR PREPARATION OF β-PHENETHYLAMINE DERIVATIVE |
-
2003
- 2003-09-25 MX MXPA05003355A patent/MXPA05003355A/es active IP Right Grant
- 2003-09-25 CA CA002501321A patent/CA2501321C/en not_active Expired - Fee Related
- 2003-09-25 AU AU2003264968A patent/AU2003264968B2/en not_active Ceased
- 2003-09-25 BR BR0315084-4A patent/BR0315084A/pt not_active IP Right Cessation
- 2003-09-25 NZ NZ538966A patent/NZ538966A/en not_active IP Right Cessation
- 2003-09-25 RU RU2005109560/15A patent/RU2290924C2/ru not_active IP Right Cessation
- 2003-09-25 WO PCT/KR2003/001955 patent/WO2004030663A1/en not_active Ceased
- 2003-09-25 HR HR20050307A patent/HRP20050307A2/xx not_active Application Discontinuation
- 2003-09-25 PL PL03375032A patent/PL375032A1/pl unknown
- 2003-09-25 EP EP03799194A patent/EP1545484A4/en not_active Withdrawn
- 2003-09-25 JP JP2005500095A patent/JP4278652B2/ja not_active Expired - Fee Related
- 2003-10-03 US US10/678,325 patent/US6900245B2/en not_active Expired - Fee Related
-
2005
- 2005-05-06 NO NO20052222A patent/NO20052222L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006506449A (ja) | 2006-02-23 |
| RU2005109560A (ru) | 2005-09-20 |
| CA2501321C (en) | 2008-07-08 |
| HK1083741A1 (en) | 2006-07-14 |
| EP1545484A4 (en) | 2010-01-13 |
| CA2501321A1 (en) | 2004-04-15 |
| AU2003264968A1 (en) | 2004-04-23 |
| RU2290924C2 (ru) | 2007-01-10 |
| HRP20050307A2 (en) | 2006-12-31 |
| AU2003264968B2 (en) | 2006-03-16 |
| NZ538966A (en) | 2006-11-30 |
| WO2004030663A1 (en) | 2004-04-15 |
| MXPA05003355A (es) | 2005-10-18 |
| US6900245B2 (en) | 2005-05-31 |
| JP4278652B2 (ja) | 2009-06-17 |
| EP1545484A1 (en) | 2005-06-29 |
| BR0315084A (pt) | 2005-08-16 |
| NO20052222L (no) | 2005-05-06 |
| US20040068018A1 (en) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0220467D0 (en) | Composition | |
| GB0213638D0 (en) | Composition | |
| GB0305941D0 (en) | Composition | |
| GB0302738D0 (en) | Composition | |
| GB0318894D0 (en) | Composition | |
| GB0203421D0 (en) | Composition | |
| GB0227244D0 (en) | Composition | |
| GB2407317B (en) | Cementing composition | |
| AU2003297594A8 (en) | Crystalline form | |
| GB0203280D0 (en) | Anti-glycolytic composition | |
| GB0208608D0 (en) | Composition | |
| GB2392618B (en) | Compositions for therapeutic use | |
| AU2003252683A8 (en) | Composition for oral use | |
| GB0211924D0 (en) | Composition | |
| GB0218241D0 (en) | Composition | |
| GB0230274D0 (en) | Composition | |
| AU2003264443A8 (en) | Preparation for external use | |
| EP1495751A4 (en) | hair dye | |
| GB0213767D0 (en) | Composition | |
| GB0229286D0 (en) | Composition | |
| GB0306312D0 (en) | Composition | |
| GB0203616D0 (en) | Composition | |
| GB0228533D0 (en) | Crystalline form | |
| GB0301869D0 (en) | Composition | |
| GB0200437D0 (en) | Composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |